| Basics |
Boston Scientific Corp.
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
|
| IPO Date: |
January 3, 1994 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$153.61B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.31 | 1.23%
|
| Avg Daily Range (30 D): |
$0.76 | 0.74%
|
| Avg Daily Range (90 D): |
$1.08 | 1.10%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
9.94M |
| Avg Daily Volume (30 D): |
5.54M |
| Avg Daily Volume (90 D): |
6.3M |
| Trade Size |
| Avg Trade Size (Sh.): |
261 |
| Avg Trade Size (Sh.) (30 D): |
68 |
| Avg Trade Size (Sh.) (90 D): |
73 |
| Institutional Trades |
| Total Inst.Trades: |
102,149 |
| Avg Inst. Trade: |
$3.1M |
| Avg Inst. Trade (30 D): |
$12.63M |
| Avg Inst. Trade (90 D): |
$11.34M |
| Avg Inst. Trade Volume: |
.11M |
| Avg Inst. Trades (Per Day): |
18 |
| Market Closing Trades |
| Avg Closing Trade: |
$25.12M |
| Avg Closing Trade (30 D): |
$143.3M |
| Avg Closing Trade (90 D): |
$132.68M |
| Avg Closing Volume: |
689.96K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$1.38
|
$.46
|
$.38
|
|
Diluted EPS
|
$1.37
|
$.45
|
$.38
|
|
Revenue
|
$ 17.55B
|
$ 4.66B
|
$ 4.56B
|
|
Gross Profit
|
$ 12.05B
|
$ 3.21B
|
$ 3.1B
|
|
Net Income / Loss
|
$ 2.02B
|
$ 672M
|
$ 562M
|
|
Operating Income / Loss
|
$ 2.85B
|
$ 921M
|
$ 675M
|
|
Cost of Revenue
|
$ 5.5B
|
$ 1.45B
|
$ 1.47B
|
|
Net Cash Flow
|
$ -1577M
|
$ 313M
|
$ -2043M
|
|
PE Ratio
|
0.00
|
|
|
|
|
|
